Product image of Irsamla (Vortioxetine Hydrobromide) supplied by GNH India

Irsamla

Active Ingredient:
Vortioxetine Hydrobromide
Origin:
EU

Irsamla (Vortioxetine Hydrobromide)

Vortioxetine, the active ingredient in Irsamla, is a serotonin modulator and stimulator presented as an oral tablet for oral use. It is indicated for the treatment of major depressive disorder in adults, helping to improve mood and functional outcomes.

GNH India supplies Irsamla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Our distribution network ensures timely delivery and compliance with local regulatory requirements.

Manufacturer / TM Owner

Egis Pharmaceuticals Plc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Vortioxetine acts on serotonergic pathways to treat depressive disorders.

  • Major depressive disorder: reduces depressive symptoms and improves functional outcomes in adult patients.
  • Depressive episodes in major depressive disorder: alleviates mood disturbances and associated cognitive deficits.
  • Treatment‑resistant major depressive disorder (adjunctive use): may be considered when other antidepressants have not achieved sufficient response.

How It Works

  • Vortioxetine modulates multiple serotonin receptors—acting as a 5‑HT1A agonist, 5‑HT1B partial agonist, and antagonist at 5‑HT3 and 5‑HT7 receptors—while also inhibiting the serotonin transporter. This combined activity enhances serotonergic neurotransmission across brain regions involved in mood regulation, cognition, and anxiety.

Side Effects

Irsamla may cause a range of adverse reactions.

Common Side Effects

  • Nausea
  • Headache
  • Dizziness
  • Dry mouth

Serious or Rare Side Effects

  • Suicidal thoughts or behavior
  • Serotonin syndrome (potentially life‑threatening)
  • Severe allergic reaction (anaphylaxis)

Precautions & Warnings

Before initiating therapy, consider the following precautions.

  • Assess psychiatric history: monitor for worsening depression or suicidal ideation.
  • Evaluate hepatic function: adjust use in patients with severe liver impairment.
  • Avoid concomitant MAO inhibitors: ensure an appropriate washout period.
  • Caution in cardiovascular disease: monitor blood pressure and heart rate.
  • Pregnancy and lactation: discuss potential risks with the prescriber.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Vortioxetine can interact with several medication classes.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome.
  • Other serotonergic agents (e.g., SSRIs, SNRIs, tramadol, linezolid, methylene blue): increased serotonin toxicity.

Moderate Interactions (Monitor Closely)

  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise vortioxetine plasma levels.
  • CYP2D6 inducers (e.g., rifampin): may reduce drug exposure.
  • Anticoagulants (e.g., warfarin): monitor INR for potential bleeding risk.

Frequently Asked Questions

Irsamla contains vortioxetine, which is prescribed to treat major depressive disorder in adult patients. It helps alleviate depressive symptoms, improve mood, and support functional recovery as part of a comprehensive treatment plan.

Vortioxetine modulates several serotonin receptors while inhibiting the serotonin transporter. This dual action increases serotonin levels and balances receptor activity, leading to enhanced neurotransmission that is associated with mood improvement and cognitive benefits.

The appropriate dose of Irsamla is individualized by the prescribing clinician based on the patient’s clinical condition, response to therapy, and any relevant medical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for vortioxetine in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and discuss these considerations with the patient before initiating therapy.

To request Irsamla, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike traditional SSRIs, vortioxetine also targets multiple serotonin receptors, which may offer advantages in cognitive symptoms and a different side‑effect profile. Clinicians consider individual patient response, tolerability, and comorbid conditions when choosing between vortioxetine and other antidepressant classes.

Store Irsamla at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure they are out of reach of children.

Irsamla is taken orally, usually once daily with or without food, as directed by the prescriber. The tablet should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious risks include the emergence of suicidal thoughts or behaviors, serotonin syndrome when combined with other serotonergic drugs, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience any of these symptoms.

Irsamla is contraindicated in patients who have taken a monoamine oxidase inhibitor within the past 14 days, those with known hypersensitivity to vortioxetine or any excipients, and individuals with uncontrolled severe hepatic impairment. Clinicians should review the full prescribing information before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Vortioxetine Hydrobromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT